The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $72.11

Today's change+1.92 +2.74%
Updated December 18 4:00 PM EST. Delayed by at least 15 minutes.
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $72.11

Today's change+1.92 +2.74%
Updated December 18 4:00 PM EST. Delayed by at least 15 minutes.

AstraZeneca PLC crosses above 200-day moving average

AstraZeneca PLC closed up sharply Thursday, rallying (U.S.)$1.92 or 2.74% to (U.S.)$72.11 and crossing above its 200-day moving average. Shares have lost 2.02% over the last five days, but have gained 21.46% over the last year to date. This security has outperformed the S&P 500 by 8.71% during the last year.

Key company metrics

  • Open(U.S.) $71.08
  • Previous close(U.S.) $70.19
  • High(U.S.) $72.15
  • Low(U.S.) $70.83
  • Bid / Ask-- / --
  • YTD % change+21.46%
  • Volume1,211,142
  • Average volume (10-day)2,509,691
  • Average volume (1-month)1,936,190
  • Average volume (3-month)2,069,546
  • 52-week range(U.S.) $57.87 to (U.S.) $82.68
  • Beta0.58
  • Trailing P/E88.75×
  • P/E 1 year forward15.83×
  • Forward PEG15.83×
  • Indicated annual dividend(U.S.) $2.80
  • Dividend yield3.88%
  • Trailing EPS(U.S.) $0.81
Updated December 18 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue6,5426,4546,4166,844
Total other revenue--------
Total revenue6,5426,4546,4166,844
Gross profit5,1845,1735,0985,426
Total cost of revenue1,3581,2811,3181,418
Total operating expense6,0015,3455,5807,435
Selling / general / administrative2,7672,6502,4364,435
Research & development1,2751,2081,0981,345
Depreciation / amortization342267267--
Interest expense (income), net operating--------
Unusual expense (income)515417677385
Other operating expenses, total-256-478-216-148
Operating income5411,109836-591
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax322866638-715
Income after tax253797506-520
Income tax, total6969132-195
Net income254796504-524
Total adjustments to net income--------
Net income before extra. items254796504-524
Minority interest1-1-2-4
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items254796504-524
Inc. avail. to common incl. extra. items254796504-524
Diluted net income254796504-524
Dilution adjustment------0
Diluted weighted average shares1,2641,2641,2621,255
Diluted EPS excluding extraordinary itemsvalue per share0.200.630.40-0.42
Dividends per sharevalue per share0.000.900.001.90
Diluted normalized EPSvalue per share0.781.121.10-0.22